4.6 Article

Stabilized β-Catenin in Thymic Epithelial Cells Blocks Thymus Development and Function

期刊

JOURNAL OF IMMUNOLOGY
卷 182, 期 5, 页码 2997-3007

出版社

AMER ASSOC IMMUNOLOGISTS
DOI: 10.4049/jimmunol.0713723

关键词

-

资金

  1. Swiss National Science Foundation [3100-61782.00, 3100-68310.02]
  2. European Community 6th Framework program Euro-Thymaide Integrated project [ROI-AI057477-01]
  3. National Institutes of Health
  4. Basel Cancer League
  5. National Health and Medical Research Council of Australia [CJ Martin Fellowship]

向作者/读者索取更多资源

Thymic T cell development is dependent on a specialized epithelial microenvironment mainly composed of cortical and medullary thymic epithelial cells (TECs). The molecular programs governing the differentiation and maintenance of TECs remain largely unknown. Wnt signaling is central to the development and maintenance of several organ systems but a specific role of this pathway for thymus organogenesis has not yet been ascertained. In this report, we demonstrate that activation or the canonical Writ signaling pathway by a stabilizing mutation of beta-catenin targeted exclusively to TECs changes the initial commitment of endodermal epithelia to a thymic cell fate. Consequently, the formation of a correctly composed and organized thymic microenvironment is prevented, thymic immigration of hematopoietic precursors is restricted, and intrathymic T cell differentiation is arrested at a very early developmental stage causing severe immunodeficiency. These results suggest that a precise regulation of canonical Wnt signaling in thymic epithelia is essential for normal thymus development and function. The Journal of Immunology, 2009, 182: 2997-3007.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Biology

The chaperonin CCT8 controls proteostasis essential for T cell maturation, selection, and function

Bergithe E. Oftedal, Stefano Maio, Adam E. Handel, Madeleine P. J. White, Duncan Howie, Simon Davis, Nicolas Prevot, Ioanna A. Rota, Mary E. Deadman, Benedikt M. Kessler, Roman Fischer, Nikolaus S. Trede, Erdinc Sezgin, Rick M. Maizels, Georg A. Hollander

Summary: This study shows that the absence of the chaperonin subunit CCT8 in T cells severely impairs T cell activation, differentiation, and immune function. The deficiency in CCT-controlled protein folding leads to abnormal cellular stress response and inefficient immune protection against pathogens such as helminths.

COMMUNICATIONS BIOLOGY (2021)

Article Biochemistry & Molecular Biology

RBFOX splicing factors contribute to a broad but selective recapitulation of peripheral tissue splicing patterns in the thymus

Kathrin Jansen, Noriko Shikama-Dorn, Moustafa Attar, Stefano Maio, Maria Lopopolo, David Buck, Georg A. Hollander, Stephen N. Sansom

Summary: Thymic epithelial cells (TEC) play a crucial role in controlling the selection of T cells reactive to pathogens. A study found that mature mTEC express a higher percentage of protein-coding transcripts compared to peripheral tissues, but produce fewer isoforms for genes with tissue-restricted expression. Furthermore, it was discovered that TEC utilize a small number of peripheral splicing factors, including members of the RBFOX family, to generate a broad but selective representation of the peripheral splice isoform repertoire.

GENOME RESEARCH (2021)

Article Biochemistry & Molecular Biology

In Vitro Characterization of Sphingosine 1-Phosphate Receptor 1 (S1P1) Expression and Mediated Migration of Primary Human T and B Cells in the Context of Cenerimod, a Novel, Selective S1P1 Receptor Modulator

Lisa Schlicher, Paulina Kulig, Audrey von Munchow, Mark J. Murphy, Marcel P. Keller

Summary: Cenerimod, a potent S1P(1) receptor modulator, effectively prevents T and B cell migration in a concentration-dependent manner. This study provides insights into the molecular role of S1P(1) receptor and the potential therapeutic application of Cenerimod in autoimmune disorders.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Multidisciplinary Sciences

P63 targeted deletion under the FOXN1 promoter disrupts pre-and post-natal thymus development, function and maintenance as well as induces severe hair loss

Heather E. Stefanski, Yan Xing, Jemma Nicholls, Leslie Jonart, Emily Goren, Patricia A. Taylor, Alea A. Mills, Megan Riddle, John McGrath, Jakub Tolar, Georg A. Hollander, Bruce R. Blazar

Summary: Progressive immune deficiency of aging is characterized by severe thymic atrophy and contracted T cell repertoire. p63 plays a critical role in thymic development and maintenance, as well as hair follicle formation.

PLOS ONE (2022)

Article Immunology

Successful Induction of Specific Immunological Tolerance by Combined Kidney and Hematopoietic Stem Cell Transplantation in HLA-Identical Siblings

Thomas Fehr, Kerstin Huebel, Olivier de Rougemont, Irene Abela, Ariana Gaspert, Tayfun Guengoer, Mathias Hauri, Birgit Helmchen, Claudia Linsenmeier, Thomas Mueller, Jakob Nilsson, Oliver Riesterer, John D. Scandling, Urs Schanz, Pietro E. Cippa

Summary: This study reports the first European clinical trial on kidney transplantation aiming to induce immunological tolerance through mixed lymphohematopoietic chimerism. The results demonstrate that combined kidney and hematopoietic stem cell transplantation from an HLA-matched sibling is a feasible and successful approach, while maintaining immune responsiveness to mRNA vaccines.

FRONTIERS IN IMMUNOLOGY (2022)

Article Immunology

CRISPR/Cas-based Human T cell Engineering: Basic Research and Clinical Application

Bettina E. Bernard, Emmanuelle Landmann, Lukas T. Jeker, Kathrin Schumann

Summary: Engineering human T cells for cancer, viral infections, and autoimmune diseases has been a dream for many immunologists and hematologists. The discovery and adaptation of CRISPR/Cas9 to human T cells have revolutionized the field, making T cell engineering more accessible and accelerating the development of engineered adoptive T cell therapies.

IMMUNOLOGY LETTERS (2022)

Article Immunology

Abrogation of Notch Signaling in Embryonic TECs Impacts Postnatal mTEC Homeostasis and Thymic Involution

Maria Jesus Garcia-Leon, Marta Mosquera, Carmela Cela, Juan Alcain, Saulius Zuklys, Georg Hollander, Maria L. Toribio

Summary: Notch signaling plays a crucial role in fate determination and development of thymus-seeding progenitors along the T-cell lineage. It is not only activated in fetal thymic epithelial cells (TECs), but also induced in postnatal cortical and medullary TECs with age. Disruption of Notch signaling leads to reduced medullary region and accelerated degeneration of medullary TECs.

FRONTIERS IN IMMUNOLOGY (2022)

Article Multidisciplinary Sciences

Developmental dynamics of the neural crest-mesenchymal axis in creating the thymic microenvironment

Adam E. Handel, Stanley Cheuk, Fatima Dhalla, Stefano Maio, Tania Huebscher, Ioanna Rota, Mary E. Deadman, Olov Ekwall, Matthias Lutolf, Kenneth Weinberg, Georg Hollaender

Summary: This study explores the complex composition and dynamic changes of the non-epithelial stromal compartment in the thymus, and reveals the heterogeneity of different stromal subtypes and their roles in thymus organogenesis and tissue maintenance.

SCIENCE ADVANCES (2022)

Article Multidisciplinary Sciences

Forced expression of the non-coding RNA miR-17∼92 restores activation and function in CD28- deficient CD4+ T cells

Marianne Dolz, Marko Hasiuk, John D. Gagnon, Mara Kornete, Romina Marone, Glenn Bantug, Robin Kageyama, Christoph Hess, K. Mark Ansel, Denis Seyres, Julien Roux, Lukas T. Jeker

Summary: CD28 provides the prototypical costimulatory signal for T cell activation. miR-17 similar to 92, induced by T cell receptor stimulation and enhanced by CD28 costimulation, acts as a central mediator for T cell activation by dampening negative regulators.

ISCIENCE (2022)

Article Multidisciplinary Sciences

Deletion of SNX9 alleviates CD8 T cell exhaustion for effective cellular cancer immunotherapy

Marcel P. Trefny, Nicole Kirchhammer, Priska Auf der Maur, Marina Natoli, Dominic Schmid, Markus Germann, Laura Fernandez Rodriguez, Petra Herzig, Jonas Lotscher, Maryam Akrami, Jane C. Stinchcombe, Michal A. Stanczak, Andreas Zingg, Melanie Buchi, Julien Roux, Romina Marone, Leyla Don, Didier Lardinois, Mark Wiese, Lukas T. Jeker, Mohamed Bentires-Alj, Jeremie Rossy, Daniela S. Thommen, Gillian M. Griffiths, Heinz Laubli, Christoph Hess, Alfred Zippelius

Summary: In this study, a human antigen-specific ex vivo model was used to explore new therapeutic options for T cell immunotherapies. The protein SNX9 was identified as a mediator of T cell exhaustion, and its knockout resulted in enhanced memory differentiation and function of adoptively transferred T cells, improving anti-tumor efficacy of chimeric antigen receptor T cells in vivo.

NATURE COMMUNICATIONS (2023)

Letter Biophysics

CD4+CAR T-cell expansion is associated with response and therapy related toxicities in patients with B-cell lymphomas

Katharina Baur, Andreas Buser, Lukas T. Jeker, Nina Khanna, Heinz Laeubli, Dominik Heim, Jan C. Dirks, Corinne C. Widmer, Thomas Volken, Jakob R. Passweg, Andreas Holbro

BONE MARROW TRANSPLANTATION (2023)

Article Chemistry, Medicinal

Discovery of Clinical Candidate ACT-777991, a Potent CXCR3 Antagonist for Antigen-Driven and Inflammatory Pathologies

Emmanuel A. Meyer, Paivi Aanismaa, Eric A. Ertel, Eva Huhn, Daniel S. Strasser, Markus Rey, Mark J. Murphy, Marianne M. Martinic, Laetitia Pouzol, Sylvie Froidevaux, Marcel P. Keller, Eva Caroff

Summary: The CXCR3 chemokine receptor plays a crucial role in immune response and inflammatory processes. In this study, a novel clinical compound called ACT-777991 was discovered as a potent and selective CXCR3 antagonist. It showed dose-dependent efficacy and target engagement in a mouse model of acute lung inflammation, indicating its potential therapeutic value.

JOURNAL OF MEDICINAL CHEMISTRY (2023)

Article Immunology

Leveraging microRNAs for cellular therapy

Marko Hasiuk, Marianne Dolz, Romina Marone, Lukas T. Jeker

Summary: Cellular therapy has evolved from traditional blood transfusion to complex manufacturing of CAR-T cells. Basic knowledge of cell biology and molecular genetics can improve modern cellular therapy products. Although most cell engineering efforts focus on proteins, miRNAs also play an important role in posttranscriptional gene regulation.

IMMUNOLOGY LETTERS (2023)

Article Immunology

Epitope-engineered human hematopoietic stem cells are shielded from CD123-targeted immunotherapy

Romina Marone, Emmanuelle Landmann, Anna Devaux, Rosalba Lepore, Denis Seyres, Jessica Zuin, Thomas Burgold, Corinne Engdahl, Giuseppina Capoferri, Alessandro Dell'Aglio, Clement Larrue, Federico Simonetta, Julia Rositzka, Manuel Rhiel, Geoffroy Andrieux, Danielle N. Gallagher, Markus S. Schroder, Amelie Wiederkehr, Alessandro Sinopoli, Valentin Do Sacramento, Anna Haydn, Laura Garcia-Prat, Christopher Divsalar, Anna Camus, Liwen Xu, Lorenza Bordoli, Torsten Schwede, Matthew Porteus, Jerome Tamburini, Jacob E. Corn, Toni Cathomen, Tatjana I. Cornu, Stefanie Urlinger, Lukas T. Jeker

Summary: Targeted immunotherapy against CD123 shows promise for hematologic diseases, but the shared expression on healthy hematopoietic stem cells poses risks. Epitope-engineered HSPCs can be shielded from immunotherapy while remaining functional. Transplantation of genome-edited HSPCs enables tumor-selective immunotherapy and reconstruction of a fully functional hematopoietic system.

JOURNAL OF EXPERIMENTAL MEDICINE (2023)

Article Cell Biology

Proteomics of immune cells from liver tumors reveals immunotherapy targets

Fernando P. Canale, Julia Neumann, Janusz von Renesse, Elisabetta Loggi, Matteo Pecoraro, Ian Vogel, Giada Zoppi, Gaia Antonini, Tobias Wolf, Wenjie Jin, Xiaoqin Zheng, Giuliano La Barba, Emrullah Birgin, Marianne Forkel, Tobias Nilsson, Romina Marone, Henrik Mueller, Nadege Pelletier, Lukas T. Jeker, Gianluca Civenni, Christoph Schlapbach, Carlo V. Catapano, Lena Seifert, Adrian M. Seifert, Silke Gillessen, Sara De Dosso, Alessandra Cristaudi, Nuh N. Rahbari, Giorgio Ercolani, Roger Geiger

Summary: Understanding how immune cells become dysfunctional in tumors is crucial for developing advanced immunotherapies. Our study revealed that certain proteins, such as SGPL1 and AFAP1L2, play a role in dampening the inflammatory response and anti-tumor function of macrophages and CD8+ T cells in liver cancer. Targeting these proteins could enhance the effectiveness of immunotherapy.

CELL GENOMICS (2023)

暂无数据